# Entrada Therapeutics, Inc.: Form 8-K, filed Jun 8, 2023

- Company: [Entrada Therapeutics, Inc.](/companies/trda.md) (CIK 1689375)
- Form: 8-K
- Filed: 2023-06-08
- Accepted by EDGAR: Jun 8, 2023, 17:11 ET
- Period: 2023-06-07
- Accession: 0001104659-23-069464
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1689375/000110465923069464/tm2318297d1_8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1689375/000110465923069464/

## Items reported

- Item 5.02: Departure or appointment of officers or directors
- Item 5.07: Shareholder vote results

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1689375/000110465923069464/tm2318297d1_8k.htm

Filed Jun 8, 2023.
Source: SEC EDGAR, the filing index for accession 0001104659-23-069464. Last ingested by Listed: Nov 5, 2026, 11:57 ET. No prices; not investment advice.